Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

PFE holding history

Pfizer Inc in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q2 2026 holdings

Shares (Q2 2026)
16,746,801
Value
$403.3M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of PFE by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,746,801$403.3M0.1%+2,057,614+14.0%AddedHolders
Q1 202614,689,187$412.5M0.1%−3,444,802−19.0%ReducedHolders
Q4 202518,133,989$451.5M0.2%−411,569−2.2%ReducedHolders
Q3 202518,545,558$472.5M0.2%+2,970,470+19.1%AddedHolders
Q2 202515,575,088$377.5M0.1%+656,946+4.4%AddedHolders
Q1 202514,918,142$378.0M0.2%−1,962,267−11.6%ReducedHolders
Q4 202416,880,409$447.8M0.2%−10,203,305−37.7%ReducedHolders
Q3 202427,083,714$783.8M0.3%+11,840,905+77.7%AddedHolders
Q2 202415,242,809$426.5M0.2%−6,322,497−29.3%ReducedHolders
Q1 202421,565,306$598.4M0.3%+9,939,752+85.5%AddedHolders
Q4 202311,625,554$334.7M0.2%−4,503,233−27.9%ReducedHolders
Q3 202316,128,787$535.0M0.3%+3,102,892+23.8%AddedHolders
Q2 202313,025,895$477.8M0.3%+6,466,670+98.6%AddedHolders
Q1 20236,559,225$267.6M0.3%−5,941,259−47.5%ReducedHolders
Q4 202212,500,484$640.5M0.6%+3,310,499+36.0%AddedHolders
Q3 20229,189,985$402.2M0.4%+1,993,130+27.7%AddedHolders
Q2 20227,196,855$377.3M0.4%−4,125,023−36.4%ReducedHolders
Q1 202211,321,878$586.1M0.5%−3,779,832−25.0%ReducedHolders
Q4 202115,101,710$891.8M0.5%+574,305+4.0%AddedHolders
Q3 202114,527,405$624.8M0.4%+4,470,323+44.4%AddedHolders
Q2 202110,057,082$393.8M0.3%+1,459,377+17.0%AddedHolders
Q1 20218,597,705$311.5M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.